FDA accepts Cingulate's drug application for ADHD treatment CTx-1301
Go back to FDA accepts Cingulate's drug application for ADHD treatment CTx-1301| (NASDAQ: CING) | Delayed: 5.38 -0.51 (8.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.89 | 52 Week High | $ | |||
| Open | $5.95 | 52 Week Low | $ | |||
| Day High | $5.95 | P/E | N/A | |||
| Day Low | $5.35 | EPS | $ | |||
| Volume | 378,205 | |||||
| (NASDAQ: CINGW) | Delayed: 0.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.02 | 52 Week High | $ | |||
| Open | $0.02 | 52 Week Low | $ | |||
| Day High | $0.02 | P/E | N/A | |||
| Day Low | $0.02 | EPS | $ | |||
| Volume | 14,064 | |||||

